为COVID-19紧急情况开发新药:美国的解剖学 响应 响应 响应 响应
Thomas J Moore1, Mariana P Socal1, Gerard Anderson1
1Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, USA.
Pharmacotherapy
|October 22, 2025
概括
美国政府在24个月内迅速开发和分发了8种COVID-19抗病毒疗法. 然而,病毒突变和人群免疫力最终使这些新疗法无效.
科学领域:
- 制药科学 制药科学
- 传染病研究 传染病研究
- 公共卫生政策 公共卫生政策
背景情况:
- 由于COVID-19的流行,需要加速开发抗病毒疗法,这个过程通常需要4-12年.
- 美国政府在公共卫生紧急情况期间重组了其方法,管理药物选择,临床试验和分销.
- 这个倡议旨在迅速解决迫切需要有效的COVID-19疗法.
研究的目的:
- 评估美国政府紧急计划在加速开发和分发新型治疗药物治疗COVID-19方面的有效性.
- 分析公共卫生危机期间与快速药物开发相关的时间表,结果和挑战.
- 确定未来的流行病准备所吸取的经验教训.
主要方法:
- 专注于2020年1月至2023年5月期间资助,测试或授权的COVID-19新型治疗剂.
- 利用了来自国家卫生研究院,FDA和BARDA的公共记录.
- 不包括疫苗,设备,诊断和重新使用的药物.
主要成果:
- 在不到24个月的时间里,开发,测试,批准和分发了8种新的治疗产品,包括6种单克隆抗体和2种口服抗病毒药物.
- 超过3000万个治疗疗程被分发,耗资290亿美元.
- 病毒突变和人群免疫力最终降低了这些治疗的有效性.
结论:
- 紧急计划成功加速了针对COVID-19的新药治疗方法的识别和测试.
- 全球临床测试网络对于快速应对流行病至关重要.
- 需要进一步的研究来开发更持久的抗病毒疗法,能够抵抗突变和改变人群免疫力.
相关概念视频
Clinical Trials: Overview
4.6K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.6K
Drug Regulation
2.7K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
2.7K
Preclinical Development: Overview
5.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.8K
Drug Discovery: Overview
11.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
11.0K
Drug Administration and Therapy Phases: Overview
1.3K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.3K
Drug Control Governance: Regulatory Bodies and Their Impact
489
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
489


